Nova Leap Valuation
| NLH Stock | CAD 0.25 0.01 3.85% |
Nova Leap seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nova Leap Health from analyzing the firm fundamentals such as Profit Margin of (0.02) %, current valuation of 21.31 M, and Return On Equity of -0.0249 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nova Leap's valuation include:
Price Book 0.8364 | Enterprise Value 21.3 M | Enterprise Value Ebitda (126.72) | Price Sales 0.8377 | Forward PE 20.4918 |
Overvalued
Today
Please note that Nova Leap's price fluctuation is out of control at this time. Calculation of the real value of Nova Leap Health is based on 3 months time horizon. Increasing Nova Leap's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nova stock is determined by what a typical buyer is willing to pay for full or partial control of Nova Leap Health. Since Nova Leap is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nova Stock. However, Nova Leap's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.22 | Hype 0.25 |
The intrinsic value of Nova Leap's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nova Leap's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nova Leap Health helps investors to forecast how Nova stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nova Leap more accurately as focusing exclusively on Nova Leap's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nova Leap's intrinsic value based on its ongoing forecasts of Nova Leap's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nova Leap's closest peers.
Nova Leap Cash |
|
Nova Valuation Trend
Analysing the historical paterns of Nova Leap's enterprise value and its market capitalization is a good way to estimate and gauge the value of Nova Leap Health over time and is usually enough for investors to make rational market timing decisions.
Nova Leap Total Value Analysis
Nova Leap Health is now estimated to have takeover price of 21.31 M with market capitalization of 23.28 M, debt of 3.97 M, and cash on hands of 1.24 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Nova Leap fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.31 M | 23.28 M | 3.97 M | 1.24 M |
Nova Leap Investor Information
About 41.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.84. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nova Leap Health recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Based on the analysis of Nova Leap's profitability, liquidity, and operating efficiency, Nova Leap Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Nova Leap Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nova Leap has an asset utilization ratio of 110.27 percent. This indicates that the Company is making C$1.1 for each dollar of assets. An increasing asset utilization means that Nova Leap Health is more efficient with each dollar of assets it utilizes for everyday operations.Nova Leap Ownership Allocation
Nova Leap Health maintains a total of 86.21 Million outstanding shares. Nova Leap Health holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nova Leap Profitability Analysis
The company reported the revenue of 26.41 M. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 9.98 M.About Nova Leap Valuation
Our relative valuation model uses a comparative analysis of Nova Leap. We calculate exposure to Nova Leap's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nova Leap's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 9.6 M | 5.2 M | |
| Pretax Profit Margin | (0.05) | (0.05) | |
| Operating Profit Margin | 0.02 | 0.02 | |
| Net Loss | (0.04) | (0.04) | |
| Gross Profit Margin | 0.37 | 0.28 |
Additional Tools for Nova Stock Analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.